We only have this paper's title and publication details.
Read it at the sourceWhile vancomycin has remained the mainstay of the treatment for methicillin-resistant
No takes yet. Share an insight, caveat, or question.
Sarıcaoğlu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: